Nanexa AB (publ) announced that Cecilia Danckwardt-Lillieström will take over as Chief Financial Officer as of September 1, 2024, as the current CFO Björn Svanström has chosen to leave the company. Cecilia has extensive experience from similar positions in the Life Science sector as well as senior roles in accounting and auditing. Cecilia holds a degree in Economics and Business Administration from Uppsala University.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.908 SEK | -0.22% | +1.57% | -26.18% |
28/06 | Nanexa AB Announces Chief Financial Officer Changes | CI |
11/06 | Nanexa AB Announces That First Patient Dosed in Nanexa's Phase I Trial of NEX-22 in Type 2 Diabetes | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.18% | 1.16Cr | |
-0.04% | 22Cr | |
-68.01% | 7.46Cr |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB
- Nanexa AB Announces Chief Financial Officer Changes